NYSE:CLB - Core Laboratories Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$112.56 -1.86 (-1.63 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$112.56
Today's Range$112.32 - $114.98
52-Week Range$86.55 - $130.34
Volume323,764 shs
Average Volume558,918 shs
Market Capitalization$5.08 billion
P/E Ratio56.28
Dividend Yield1.91%
Beta1.46
Core Laboratories logoCore Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
SymbolNYSE:CLB
CUSIPN/A
Phone31-20-420-3191

Debt

Debt-to-Equity Ratio1.55
Current Ratio2.11
Quick Ratio1.76

Price-To-Earnings

Trailing P/E Ratio56.28
Forward P/E Ratio45.20
P/E GrowthN/A

Sales & Book Value

Annual Sales$659.81 million
Price / Sales7.54
Cash Flow$2.5125 per share
Price / Cash44.80
Book Value$3.37 per share
Price / Book33.40

Profitability

EPS (Most Recent Fiscal Year)$2.00
Net Income$83.12 million
Net Margins13.24%
Return on Equity62.69%
Return on Assets16.15%

Miscellaneous

Employees4,600
Outstanding Shares44,200,000
Market Cap$5,082.44

Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 13th. Investors of record on Monday, July 23rd will be given a dividend of $0.55 per share on Monday, August 13th. This represents a $2.20 annualized dividend and a yield of 1.95%. The ex-dividend date is Friday, July 20th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, April, 25th. The oil and gas company reported $0.57 earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of $0.57. The oil and gas company had revenue of $170 million for the quarter, compared to analyst estimates of $171.03 million. Core Laboratories had a return on equity of 62.69% and a net margin of 13.24%. The company's revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the business earned $0.42 EPS. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its third quarter earnings guidance on Monday, July, 2nd. The company provided EPS guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.74. The company issued revenue guidance of $177-179 million, compared to the consensus revenue estimate of $187.06 million.Core Laboratories also updated its Q2 guidance to $0.57-0.59 EPS.

What price target have analysts set for CLB?

11 analysts have issued 12-month target prices for Core Laboratories' stock. Their predictions range from $96.00 to $136.00. On average, they expect Core Laboratories' stock price to reach $113.9940 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price. View Analyst Ratings for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Core Laboratories' key competitors?

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 63)
  • Mr. Monty L. Davis, Chief Operating Officer and Sr. VP (Age 64)
  • Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 58)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 48)
  • Mr. Kevin Daniels, Chief Accounting Officer & Corp. Group Controller (Age 55)

Has Core Laboratories been receiving favorable news coverage?

Media headlines about CLB stock have been trending somewhat positive on Saturday, Accern Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Core Laboratories earned a media sentiment score of 0.17 on Accern's scale. They also gave news coverage about the oil and gas company an impact score of 45.87 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (1.02%), Manning & Napier Group LLC (0.19%), Franklin Street Advisors Inc. NC (0.18%), Gofen & Glossberg LLC IL (0.13%), Bank of Montreal Can (0.10%) and Forte Capital LLC ADV (0.04%). Company insiders that own Core Laboratories stock include Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan. View Insider Buying and Selling for Core Laboratories.

Which major investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Bank of Montreal Can, Fisher Asset Management LLC, Forte Capital LLC ADV, First Citizens Bank & Trust Co., Creative Planning, World Asset Management Inc and Franklin Street Advisors Inc. NC. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $112.56.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $5.08 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  322 (Vote Outperform)
Underperform Votes:  458 (Vote Underperform)
Total Votes:  780
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.